NCT00722956View on ClinicalTrials.gov

Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy VolunteersPharmacokinetics
Interventions
DRUG

AZD5672

100 mg once daily, 10 days

DRUG

atorvastatin

one single dose of 40 mg on day 10

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY